ELIZABETH PFEIFFER: Open Payments
NPI 1124252879 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 17 payments from 9 companies in 2025. Trend: 2023 $234 · 2024 $154 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $112 |
| Alkermes, Inc. | 3 | $67 |
| Lundbeck LLC | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Corium, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: AUSTEDO XR, ARISTADA, ABILIFY ASIMTUFII, INGREZZA, REXULTI, UZEDY, Jornay PM, Qelbree.
Industry payments across IN — which companies pay providers there.
